ArticleThe journal of pain2026

A qualitative study examining barriers to buprenorphine for pain management in patients with end stage kidney disease undergoing hemodialysis.

Karlyn A Edwards et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.